×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Cape Town-based Afrigen Biologics has signed an agreement with Belgian Univercells Group to develop a novel mRNA Covid-19 vaccine that is cheaper and easier to store than jabs now on the market.

If successful, this will be the first African-owned coronavirus vaccine, and it will boost the continent’s ambitions to reduce reliance on imports...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now